Prostate Adenocarcinoma Clinical Trials in Clackamas, Oregon

3 studies are recruiting for prostate adenocarcinoma in Clackamas, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a p…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Clackamas Radiation Oncology Center, Clackamas, Oregon
    Locations
    413 in total
    Run by
    NRG Oncology

    See if you can join NCT05946213 on ClinicalTrials.gov

  2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective c…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Clackamas Radiation Oncology Center, Clackamas, Oregon
    Locations
    341 in total
    Run by
    ECOG-ACRIN Cancer Research Group

    See if you can join NCT04423211 on ClinicalTrials.gov

  3. Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

    This phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug ci…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Clackamas Radiation Oncology Center, Clackamas, Oregon
    Locations
    133 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT05806515 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.